A detailed history of Simplex Trading, LLC transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 19,500 shares of ELEV stock, worth $11,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,500
Previous 147 13165.31%
Holding current value
$11,114
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$0.56 - $3.02 $10,837 - $58,446
19,353 Added 13165.31%
19,500 $11,000
Q2 2024

Jul 25, 2024

BUY
$2.35 - $5.17 $345 - $759
147 New
147 $0

Others Institutions Holding ELEV

About Elevation Oncology, Inc.


  • Ticker ELEV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,300,900
  • Market Cap $13.3M
  • Description
  • Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...
More about ELEV
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.